Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors

Frontiers in Oncology

Volumn 3 MAY, Issue , 2013, Pages

  Belinsky, Martin G ^a   Rink, Lori ^a   von Mehren, Margaret ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Gastrointestinal stromal tumor; Insulin like growth factor receptor; Review; Succinate dehydrogenase; Wild type

Indexed keywords

BEVACIZUMAB; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMATINIB; LINSITINIB; MOTESANIB; NILOTINIB; NVP AEW 541; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; REGORAFENIB; SOMATOMEDIN C RECEPTOR; SORAFENIB; SUCCINATE DEHYDROGENASE; SUNITINIB; VASCULOTROPIN; VATALANIB;

COMPLEX II DEFICIENCY; CYTOGENETICS; DISEASE ASSOCIATION; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PEDIATRICS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SDHA GENE; TUMOR GROWTH;

EID: 84891067744     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00117     Document Type: Review

References (133)

1. Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., et al. (2010). A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249.
2. Agaimy, A., Pelz, A. F., Corless, C. L., Wunsch, P. H., Heinrich, M. C., Hofstaedter, F., et al. (2007). Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol. Rep. 18, 9-15.
3. Agaimy, A., Terracciano, L. M., Dirnhofer, S., Tornillo, L., Foerster, A., Hartmann, A., et al. (2009). V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. J. Clin. Pathol. 62, 613-616.
4. Agaram, N. P., Laquaglia, M. P., Ustun, B., Guo, T., Wong, G. C., Socci, N. D., et al. (2008a). Molecular characterization of pediatric gastrointestinal stromal tumors. Clin. Cancer Res. 14, 3204-3215.
5. Agaram, N. P., Wong, G. C., Guo, T., Maki, R. G., Singer, S., Dematteo, R. P., et al. (2008b). Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 47, 853-859.
6. Agarwal, R., and Robson, M. (2009). Inherited predisposition to gastrointestinal stromal tumor. Hematol. Oncol. Clin. North Am. 23, 1-13.
7. Andersson, J., Sihto, H., Meis-Kindblom, J. M., Joensuu, H., Nupponen, N., and Kindblom, L. G. (2005). NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am. J. Surg. Pathol. 29, 1170-1176.
8. Antonescu, C. R., Viale, A., Sarran, L., Tschernyavsky, S. J., Gonen, M., Segal, N. H., et al. (2004). Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin. Cancer Res. 10, 3282-3290.
9. Assamaki, R., Sarlomo-Rikala, M., Lopez-Guerrero, J. A., Lasota, J., Andersson, L. C., Llombart-Bosch, A., et al. (2007). Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors. Genes Chromosomes Cancer 46, 564-576.
10. Astolfi, A., Nannini, M., Pantaleo, M. A., Di Battista, M., Heinrich, M. C., Santini, D., et al. (2010). A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. Lab. Invest. 90, 1285-1294.
11. Astuti, D., Latif, F., Dallol, A., Dahia, P. L., Douglas, F., George, E., et al. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49-54.
12. Bano, G., Siedel, V., Beharry, N., Wilson, P., Cranston, T., and Hodgson, S. (2012). A complex endocrine conundrum. Fam. Cancer. doi:10.1007/s10689-012-9594-7
13. Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., et al. (2000). Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851.
14. Belinsky, M. G., Rink, L., Cai, K. Q., Ochs, M. F., Eisenberg, B., Huang, M., et al. (2008). The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell Cycle 7, 2949-2955.
15. Belinsky, M. G., Rink, L., Flieder, D. B., Jahromi, M. S., Schiffman, J. D., Godwin, A. K., et al. (2012). Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors. Genes Chromosomes Cancer 52, 214-224.
16. Belinsky, M. G., Skorobogatko, Y. V., Rink, L., Pei, J., Cai, K. Q., Vanderveer, L. A., et al. (2009). High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer 48, 886-896.
17. Benesch, M., Wardelmann, E., Ferrari, A., Brennan, B., and Verschuur, A. (2009). Gastrointestinal stromal tumors (GIST) in children and adolescents: a comprehensive review of the current literature. Pediatr. Blood Cancer 53, 1171-1179.
18. Blay, J. Y., and von Mehren, M. (2011). Nilotinib: a novel, selective tyrosine kinase inhibitor. Semin. Oncol. 38(Suppl. 1), S3-S9.
19. Boguszewski, C. L., Fighera, T. M., Bornschein, A., Marques, F. M., Denes, J., Rattenbery, E., et al. (2012). Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma. Arq. Bras. Endocrinol. Metabol. 56, 507-512.
20. Bond, M., Bernstein, M. L., Pappo, A., Schultz, K. R., Krailo, M., Blaney, S. M., et al. (2008). A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr. Blood Cancer 50, 254-258.
21. Breiner, J. A., Meis-Kindblom, J., Kindblom, L. G., McComb, E., Liu, J., Nelson, M., et al. (2000). Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet. Cytogenet. 120, 111-116.
22. Burnichon, N., Briere, J. J., Libe, R., Vescovo, L., Riviere, J., Tissier, F., et al. (2010). SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011-3020.
23. Carney, J. A. (1983). The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review. Medicine (Baltimore) 62, 159-169.
24. Carney, J. A. (1999). Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin. Proc. 74, 543-552.
25. Carney, J. A. (2009). Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. J. Clin. Endocrinol. Metab. 94, 3656-3662.
26. Carney, J. A., Sheps, S. G., Go, V. L., and Gordon, H. (1977). The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N. Engl. J. Med. 296, 1517-1518.
27. Carney, J. A., and Stratakis, C. A. (2002). Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am. J. Med. Genet. 108, 132-139.
28. Cauchi, C., Somaiah, N., Engstrom, P. F., Litwin, S., Lopez, M., Lee, J., et al. (2012). Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemother. Pharmacol. 69, 977-982.
29. Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., and McCreath, K. J. (2008). Cells silenced for SDHB expression display characteristic features of the tumor phenotype. Cancer Res. 68, 4058-4067.
30. Chase, W. H. (1933). Familial and bilateral tumors of the carotid body. J. Pathol. Bacteriol. 36, 1.
31. Chedid, A., and Jao, W. (1974). Hereditary tumors of the carotid bodies and chronic obstructive pulmonary disease. Cancer 33, 1635-1641.
32. Chen, Y., Tzeng, C. C., Liou, C. P., Chang, M. Y., Li, C. F., and Lin, C. N. (2004). Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors. J. Biomed. Sci. 11, 65-71.
33. Chou, A., Chen, J., Clarkson, A., Samra, J. S., Clifton-Bligh, R. J., Hugh, T. J., et al. (2012). Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Mod. Pathol. 25, 1307-1313.
34. Comino-Mendez, I., Gracia-Aznarez, F. J., Schiavi, F., Landa, I., Leandro-Garcia, L. J., Leton, R., et al. (2011). Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 43, 663-667.
35. Corless, C. L., Barnett, C. M., and Heinrich, M. C. (2011). Gastrointestinal stromal tumours: origin and molecular oncology. Nat. Rev. Cancer 11, 865-878.
36. Corless, C. L., Beadling, C., Justusson, E., and Heinrich, M. C. (2009). Evaluation of the presence of IGF1R overexpression in wild-type and kinase mutant GI stromal tumors. J. Clin. Oncol. 27, 10506.
37. Cypriano, M. S., Jenkins, J. J., Pappo, A. S., Rao, B. N., and Daw, N. C. (2004). Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer 101, 39-50.
38. Dahia, P. L., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., et al. (2005). A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 1:e8. doi:10.1371/journal.pgen.0010008
39. Day, F. L., Desai, J., Corless, C. L., Heinrich, M. C., and Zalcberg, J. (2011). Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody. Med. Oncol. 28(Suppl. 1), S162-S164.
40. Debiec-Rychter, M., Lasota, J., Sarlomo-Rikala, M., Kordek, R., and Miettinen, M. (2001). Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genet. Cytogenet. 128, 24-30.
41. Delemarre, L., Aronson, D., Van Rijn, R., Bras, H., Arets, B., and Verschuur, A. (2008). Respiratory symptoms in a boy revealing Carney triad. Pediatr. Blood Cancer 50, 399-401.
42. Demetri, G. D. (2011). Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. Semin. Oncol. 38(Suppl. 1), S10-S19.
43. Demetri, G. D., Von Mehren, M., Antonescu, C. R., Dematteo, R. P., Ganjoo, K. N., Maki, R. G., et al. (2010). NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J. Natl. Compr. Canc. Netw. 8(Suppl. 2), S1-S41. [quiz S42-S44].
44. Douwes Dekker, P. B., Hogendoorn, P. C., Kuipers-Dijkshoorn, N., Prins, F. A., Van Duinen, S. G., Taschner, P. E., et al. (2003). SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 201, 480-486.
45. Doyle, L. A., Nelson, D., Heinrich, M. C., Corless, C. L., and Hornick, J. L. (2012). Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study. Histopathology 61, 801-809.
46. Dubreuil, P., Letard, S., Ciufolini, M., Gros, L., Humbert, M., Casteran, N., et al. (2009). Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS ONE 4:e7258. doi:10.1371/journal.pone.0007258
47. Dwight, T., Benn, D. E., Clarkson, A., Vilain, R., Lipton, L., Robinson, B. G., et al. (2012). Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors. Am. J. Surg. Pathol. 37, 226-233.
48. El-Rifai, W., Sarlomo-Rikala, M., Andersson, L. C., Knuutila, S., and Miettinen, M. (2000a). DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 60, 3899-3903.
49. El-Rifai, W., Sarlomo-Rikala, M., Andersson, L. C., Miettinen, M., and Knuutila, S. (2000b). High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer 27, 387-391.
50. el-Rifai, W., Sarlomo-Rikala, M., Miettinen, M., Knuutila, S., and Andersson, L. C. (1996). DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res. 56, 3230-3233.
51. Favier, J., Igaz, P., Burnichon, N., Amar, L., Libe, R., Badoual, C., et al. (2012). Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr. Pathol. 23, 34-42.
52. Gaal, J., Stratakis, C. A., Carney, J. A., Ball, E. R., Korpershoek, E., Lodish, M. B., et al. (2011). SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod. Pathol. 24, 147-151.
53. Gill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., et al. (2010a). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum. Pathol. 41, 805-814.
54. Gill, A. J., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., et al. (2010b). Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am. J. Surg. Pathol. 34, 636-644.
55. Gold, J. S., Van Der Zwan, S. M., Gonen, M., Maki, R. G., Singer, S., Brennan, M. F., et al. (2007). Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann. Surg. Oncol. 14, 134-142.
56. Gunawan, B., Schulten, H. J., Von Heydebreck, A., Schmidt, B., Enders, C., Hoer, J., et al. (2004). Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J. Pathol. 202, 421-429.
57. Gunawan, B., Von Heydebreck, A., Sander, B., Schulten, H. J., Haller, F., Langer, C., et al. (2007). An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. J. Pathol. 211, 463-470.
58. Hao, H. X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J. P., Kunst, H., et al. (2009). SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325, 1139-1142.
59. Hayashi, Y., Okazaki, T., Yamataka, A., Yanai, T., Yamashiro, Y., Tsurumaru, M., et al. (2005). Gastrointestinal stromal tumor in a child and review of the literature. Pediatr. Surg. Int. 21, 914-917.
60. Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C. J., Joseph, N., et al. (2003). PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708-710.
61. Heinrich, M. C., Maki, R. G., Corless, C. L., Antonescu, C. R., Harlow, A., Griffith, D., et al. (2008a). Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J. Clin. Oncol. 26, 5352-5359.
62. Heinrich, M. C., Owzar, K., Corless, C. L., Hollis, D., Borden, E. C., Fletcher, C. D., et al. (2008b). Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J. Clin. Oncol. 26, 5360-5367.
63. Heutink, P., Van Der Mey, A. G., Sandkuijl, L. A., Van Gils, A. P., Bardoel, A., Breedveld, G. J., et al. (1992). A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum. Mol. Genet. 1, 7-10.
64. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., et al. (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580.
65. Hirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., et al. (2003). Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125, 660-667.
66. Hofstra, R. M., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., et al. (1994). A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375-376.
67. Hostein, I., Faur, N., Primois, C., Boury, F., Denard, J., Emile, J. F., et al. (2010). BRAF mutation status in gastrointestinal stromal tumors. Am. J. Clin. Pathol. 133, 141-148.
68. Huang, K. T., Dobrovic, A., and Fox, S. B. (2009). No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer. BMC Res. Notes 2:194. doi:10.1186/1756-0500-2-194
69. Italiano, A., Chen, C. L., Sung, Y. S., Singer, S., Dematteo, R. P., Laquaglia, M. P., et al. (2012). SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors. BMC Cancer 12:408. doi:10.1186/1471-2407-12-408
70. Janeway, K. A., Albritton, K. H., Van Den Abbeele, A. D., D'amato, G. Z., Pedrazzoli, P., Siena, S., et al. (2009). Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr. Blood Cancer 52, 767-771.
71. Janeway, K. A., Kim, S. Y., Lodish, M., Nose, V., Rustin, P., Gaal, J., et al. (2011). Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl. Acad. Sci. U.S.A. 108, 314-318.
72. Janeway, K. A., Liegl, B., Harlow, A., Le, C., Perez-Atayde, A., Kozakewich, H., et al. (2007). Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Cancer Res. 67, 9084-9088.
73. Janeway, K. A., and Pappo, A. (2012). Treatment guidelines for gastrointestinal stromal tumors in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2), S69-S72.
74. Janeway, K. A., Zhu, M. J., Barretina, J., Perez-Atayde, A., Demetri, G. D., and Fletcher, J. A. (2010). Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification. Int. J. Cancer 127, 2718-2722.
75. Kerr, J. Z., Hicks, M. J., Nuchtern, J. G., Saldivar, V., Heim-Hall, J., Shah, S., et al. (1999). Gastrointestinal autonomic nerve tumors in the pediatric population: a report of four cases and a review of the literature. Cancer 85, 220-230.
76. Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., et al. (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. doi:10.1158/2159-8290.CD-13-0092
77. Kim, E. J., and Zalupski, M. M. (2011). Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinib. J. Surg. Oncol. 104, 901-906.
78. Kim, N. G., Kim, J. J., Ahn, J. Y., Seong, C. M., Noh, S. H., Kim, C. B., et al. (2000). Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int. J. Cancer 85, 633-638.
79. Kindblom, L. G., Remotti, H. E., Aldenborg, F., and Meis-Kindblom, J. M. (1998). Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 152, 1259-1269.
80. Knop, S., Schupp, M., Wardelmann, E., Stueker, D., Horger, M. S., Kanz, L., et al. (2006). A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor alpha. J. Clin. Pathol. 59, 1097-1099.
81. Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., Van Gessel, B., Oudijk, L., et al. (2011). SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J. Clin. Endocrinol. Metab. 96, E1472-E1476.
82. Kumar, P., Henikoff, S., and Ng, P. C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081.
83. Kuroiwa, M., Hiwatari, M., Hirato, J., Suzuki, N., Tsuchida, Y., Shimada, A., et al. (2005). Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. J. Pediatr. Surg. 40, 1798-1801.
84. Lasota, J., Wang, Z., Kim, S. Y., Helman, L., and Miettinen, M. (2012). Expression of the receptor for Type I insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications. Am. J. Surg. Pathol. 37, 114-119.
85. Lasota, J., Wozniak, A., Kopczynski, J., Dansonka-Mieszkowska, A., Wasag, B., Mitsuhashi, T., et al. (2005). Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Lab. Invest. 85, 237-247.
86. Le Cesne, A., Blay, J. Y., Bui, B. N., Bouche, O., Adenis, A., Domont, J., et al. (2010). Phase II study of oral masitinib mesilate in imatinib-naive patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). Eur. J. Cancer 46, 1344-1351.
87. Linehan, W. M., and Ricketts, C. J. (2012). The metabolic basis of kidney cancer. Semin. Cancer Biol. 63, 244-251.
88. Lorincz, A., Redelman, D., Horvath, V. J., Bardsley, M. R., Chen, H., and Ordog, T. (2008). Progenitors of interstitial cells of cajal in the postnatal murine stomach. Gastroenterology 134, 1083-1093.
89. Mariman, E. C., Van Beersum, S. E., Cremers, C. W., Struycken, P. M., and Ropers, H. H. (1995). Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum. Genet. 95, 56-62.
90. Matyakhina, L., Bei, T. A., McWhinney, S. R., Pasini, B., Cameron, S., Gunawan, B., et al. (2007). Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J. Clin. Endocrinol. Metab. 92, 2938-2943.
91. McWhinney, S. R., Pasini, B., and Stratakis, C. A. (2007). Familial gastrointestinal stromal tumors and germ-line mutations. N. Engl. J. Med. 357, 1054-1056.
92. Miettinen, M., Fetsch, J. F., Sobin, L. H., and Lasota, J. (2006a). Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am. J. Surg. Pathol. 30, 90-96.
93. Miettinen, M., Makhlouf, H., Sobin, L. H., and Lasota, J. (2006b). Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am. J. Surg. Pathol. 30, 477-489.
94. Miettinen, M., Killian, J. K., Wang, Z. F., Lasota, J., Lau, C., Jones, L., et al. (2012). Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am. J. Surg. Pathol. 37, 234-240.
95. Miettinen, M., Lasota, J., and Sobin, L. H. (2005a). Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am. J. Surg. Pathol. 29, 1373-1381.
96. Miettinen, M., Sobin, L. H., and Lasota, J. (2005b). Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am. J. Surg. Pathol. 29, 52-68.
97. Miettinen, M., Wang, Z. F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., and Lasota, J. (2011). Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am. J. Surg. Pathol. 35, 1712-1721.
98. Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., et al. (1993). Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460.
99. Niemann, S., Becker-Follmann, J., Nurnberg, G., Ruschendorf, F., Sieweke, N., Hugens-Penzel, M., et al. (2001). Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma. Am. J. Med. Genet. 98, 32-36.
100. Niemann, S., and Muller, U. (2000). Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26, 268-270.
101. Oudijk, L., Gaal, J., Korpershoek, E., Van Nederveen, F. H., Kelly, L., Schiavon, G., et al. (2012). SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors. Mod. Pathol. 26, 456-463.
102. Ozer, A., and Bruick, R. K. (2007). Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat. Chem. Biol. 3, 144-153.
103. Pantaleo, M. A., Astolfi, A., Di Battista, M., Heinrich, M. C., Paterini, P., Scotlandi, K., et al. (2009). Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. Int. J. Cancer 125, 2991-2994.
104. Pantaleo, M. A., Astolfi, A., Indio, V., Moore, R., Thiessen, N., Heinrich, M. C., et al. (2011a). SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J. Natl. Cancer Inst. 103, 983-987.
105. Pantaleo, M. A., Astolfi, A., Nannini, M., Ceccarelli, C., Formica, S., Santini, D., et al. (2011b). Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. Histopathology 59, 1071-1080.
106. Pantaleo, M. A., Nannini, M., Astolfi, A., and Biasco, G. (2011c). A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. Am. J. Surg. Pathol. 35, 1750-1752.
107. Pantaleo, M. A., Nannini, M., Saponara, M., Gnocchi, C., Di Scioscio, V., Lolli, C., et al. (2012). Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumours. Anticancer Drugs 23, 567-572.
108. Pappo, A. S., and Janeway, K. A. (2009). Pediatric gastrointestinal stromal tumors. Hematol. Oncol. Clin. North Am. 23, 15-34.
109. Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., et al. (2008). Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur. J. Hum. Genet. 16, 79-88.
110. Pasini, B., and Stratakis, C. A. (2009). SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the pheochromocytoma-paraganglioma syndromes. J. Intern. Med. 266, 19-42.
111. Prakash, S., Sarran, L., Socci, N., Dematteo, R. P., Eisenstat, J., Greco, A. M., et al. (2005). Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J. Pediatr. Hematol. Oncol. 27, 179-187.
112. Pugh, C. W., and Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
113. Pylkkanen, L., Sarlomo-Rikala, M., Wessman, M., Hamalainen, E., Sainio, M., Husgafvel-Pursiainen, K., et al. (2003). Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors. Hum. Pathol. 34, 872-879.
114. Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., et al. (2010). Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat. Genet. 42, 229-233.
115. Rege, T. A., Wagner, A. J., Corless, C. L., Heinrich, M. C., and Hornick, J. L. (2011). "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am. J. Surg. Pathol. 35, 495-504.
116. Ricketts, C., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., et al. (2008). Germline SDHB mutations and familial renal cell carcinoma. J. Natl. Cancer Inst. 100, 1260-1262.
117. Rink, L., and Godwin, A. K. (2009). Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population. Curr. Oncol. Rep. 11, 314-321.
118. Rubin, B. P., Singer, S., Tsao, C., Duensing, A., Lux, M. L., Ruiz, R., et al. (2001). KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61, 8118-8121.
119. Sauseng, W., Benesch, M., Lackner, H., Urban, C., Kronberger, M., Gadner, H., et al. (2007). Clinical, radiological, and pathological findings in four children with gastrointestinal stromal tumors of the stomach. Pediatr. Hematol. Oncol. 24, 209-219.
120. Schofield, C. J., and Zhang, Z. (1999). Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr. Opin. Struct. Biol. 9, 722-731.
121. Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., et al. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77-85.
122. Sircar, K., Hewlett, B. R., Huizinga, J. D., Chorneyko, K., Berezin, I., and Riddell, R. H. (1999). Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am. J. Surg. Pathol. 23, 377-389.
123. Stratakis, C. A., and Carney, J. A. (2009). The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J. Intern. Med. 266, 43-52.
124. Tarn, C., Rink, L., Merkel, E., Flieder, D., Pathak, H., Koumbi, D., et al. (2008). Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc. Natl. Acad. Sci. U.S.A. 105, 8387-8392.
125. Tennant, D. A., Duran, R. V., and Gottlieb, E. (2010). Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 10, 267-277.
126. van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., De Bruyn, E. M., et al. (2009). An immunohistochemical procedure to detect patients with paraganglioma and pheochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 10, 764-771.
127. Wagner, A. J., Remillard, S. P., Zhang, Y. X., Doyle, L. A., George, S., and Hornick, J. L. (2012). Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod. Pathol. 26, 289-294.
128. Welander, J., Soderkvist, P., and Gimm, O. (2011). Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr. Relat. Cancer 18, R253-R276.
129. Wozniak, A., Sciot, R., Guillou, L., Pauwels, P., Wasag, B., Stul, M., et al. (2007). Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer 46, 261-276.
130. Yang, D., Ylipaa, A., Yang, J., Hunt, K., Pollock, R., Trent, J., et al. (2010). An integrated study of aberrant gene copy number and gene expression in GIST and LMS. Technol. Cancer Res. Treat. 9, 171-178.
131. Yang, J., Du, X., Lazar, A. J., Pollock, R., Hunt, K., Chen, K., et al. (2008). Genetic aberrations of gastrointestinal stromal tumors. Cancer 113, 1532-1543.
132. Ylipaa, A., Hunt, K. K., Yang, J., Lazar, A. J., Torres, K. E., Lev, D. C., et al. (2011). Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors. Cancer 117, 380-389.
133. Zhang, L., Smyrk, T. C., Young, W. F. Jr., Stratakis, C. A., and Carney, J. A. (2010). Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am. J. Surg. Pathol. 34, 53-64.